Multicenter, Single-arm, Phase IV Study to Evaluate the Efficacy, Safety of Combined Therapy of Aspirin and High Dose 'IVIG-SN' in Pediatric Patients With Kawasaki Disease.
Phase of Trial: Phase IV
Latest Information Update: 19 Sep 2012
At a glance
- Drugs Aspirin; Immunoglobulin G
- Indications Coronary artery disease; Embolism and thrombosis; Mucocutaneous lymph node syndrome
- Focus Therapeutic Use
- Sponsors Green Cross
- 01 Sep 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 06 Feb 2012 New trial record